Waters Corp. (WAT) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Waters Corp. (WAT) PT, Estimates Raised at Jefferies Post Q2
July 23, 2014 9:00 AM EDTJefferies analyst Brandon Couillard raised his price target on Waters Corp. (NYSE: WAT) to $105.00 (from $98.00) following Q2 results but maintained a Hold rating.
Couillard comments, "Post WAT's 2Q14 print, we are raising our 2014 & 2015 EPS forecasts to $5.32 (from $5.30) and $5.82 (from $5.80), respectively, which imply... More
Waters Corp. (WAT) Acquires MediMass' REIMS Technology
July 22, 2014 9:48 AM EDTWaters Corp. (NYSE: WAT) announced the acquisition of Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass Ltd. The REIMS technology represents substantially all of the assets of MediMass and includes patent applications, software, databases and REIMS expertise.
While showing promise across many applications, REIMS technology significantly strengthens Waters technology position within Health Sciences, said Rohit Khanna, Vice-President, Worldwide Marketing and Informatics, Waters Division. This technology acquisition along with our... More
